EP1073437A4 - TREATING GENERAL FEELING WITH PAROXETINE - Google Patents

TREATING GENERAL FEELING WITH PAROXETINE

Info

Publication number: EP1073437A4
Authority: EP; European Patent Office
Prior art keywords: paroxetine; treatment; anxiety disorder; generalized anxiety; generalized
Prior art date: 1998-04-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99921431A

Other languages

German (de)

English (en)

French (fr)

Other versions

EP1073437A1 (en

Inventor

Rocco Zaninelli

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-22

Filing date

1999-04-22

Publication date

2003-04-16

1999-04-22 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2001-02-07 Publication of EP1073437A1 publication Critical patent/EP1073437A1/en

2003-04-16 Publication of EP1073437A4 publication Critical patent/EP1073437A4/en

Status Withdrawn legal-status Critical Current

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
208000011688 Generalised anxiety disease Diseases 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
208000029364 generalized anxiety disease Diseases 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EP99921431A 1998-04-22 1999-04-22 TREATING GENERAL FEELING WITH PAROXETINE Withdrawn EP1073437A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9808479.1A GB9808479D0 (en)	1998-04-22	1998-04-22	Method of treatment
GB9808479		1998-04-22
PCT/US1999/008786 WO1999053919A1 (en)	1998-04-22	1999-04-22	Treatment of generalized anxiety disorder with paroxetine

Publications (2)

Publication Number	Publication Date
EP1073437A1 EP1073437A1 (en)	2001-02-07
EP1073437A4 true EP1073437A4 (en)	2003-04-16

Family

ID=10830715

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99921431A Withdrawn EP1073437A4 (en)	1998-04-22	1999-04-22	TREATING GENERAL FEELING WITH PAROXETINE

Country Status (20)

Country	Link
EP (1)	EP1073437A4 (cs)
JP (1)	JP2002512189A (cs)
KR (1)	KR20010034817A (cs)
CN (1)	CN1298301A (cs)
AP (1)	AP2000001959A0 (cs)
AU (1)	AU3864899A (cs)
BG (1)	BG104939A (cs)
BR (1)	BR9909791A (cs)
CA (1)	CA2328896A1 (cs)
CZ (1)	CZ20003885A3 (cs)
EA (1)	EA200001088A1 (cs)
GB (1)	GB9808479D0 (cs)
HU (1)	HUP0101350A3 (cs)
ID (1)	ID27546A (cs)
IL (1)	IL139167A0 (cs)
NO (1)	NO20005286L (cs)
PL (1)	PL343494A1 (cs)
SK (1)	SK15672000A3 (cs)
TR (1)	TR200003082T2 (cs)
WO (1)	WO1999053919A1 (cs)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2297550A (en) *	1995-02-06	1996-08-07	Smithkline Beecham Plc	Forms of paroxetine hydrochloride
WO1997003670A1 (en) *	1995-07-20	1997-02-06	Smithkline Beecham P.L.C.	Paroxetine controlled release compositions

1998
- 1998-04-22 GB GBGB9808479.1A patent/GB9808479D0/en not_active Ceased
1999
- 1999-04-22 SK SK1567-2000A patent/SK15672000A3/sk unknown
- 1999-04-22 KR KR1020007011729A patent/KR20010034817A/ko not_active Withdrawn
- 1999-04-22 JP JP2000544323A patent/JP2002512189A/ja not_active Withdrawn
- 1999-04-22 IL IL13916799A patent/IL139167A0/xx unknown
- 1999-04-22 WO PCT/US1999/008786 patent/WO1999053919A1/en not_active Ceased
- 1999-04-22 CN CN99805328A patent/CN1298301A/zh active Pending
- 1999-04-22 CZ CZ20003885A patent/CZ20003885A3/cs unknown
- 1999-04-22 TR TR2000/03082T patent/TR200003082T2/xx unknown
- 1999-04-22 EA EA200001088A patent/EA200001088A1/ru unknown
- 1999-04-22 CA CA002328896A patent/CA2328896A1/en not_active Abandoned
- 1999-04-22 ID IDW20002124A patent/ID27546A/id unknown
- 1999-04-22 PL PL99343494A patent/PL343494A1/xx not_active Application Discontinuation
- 1999-04-22 EP EP99921431A patent/EP1073437A4/en not_active Withdrawn
- 1999-04-22 AP APAP/P/2000/001959A patent/AP2000001959A0/en unknown
- 1999-04-22 AU AU38648/99A patent/AU3864899A/en not_active Abandoned
- 1999-04-22 BR BR9909791-5A patent/BR9909791A/pt not_active IP Right Cessation
- 1999-04-22 HU HU0101350A patent/HUP0101350A3/hu unknown
2000
- 2000-10-20 NO NO20005286A patent/NO20005286L/no not_active Application Discontinuation
- 2000-11-13 BG BG104939A patent/BG104939A/bg unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2297550A (en) *	1995-02-06	1996-08-07	Smithkline Beecham Plc	Forms of paroxetine hydrochloride
WO1997003670A1 (en) *	1995-07-20	1997-02-06	Smithkline Beecham P.L.C.	Paroxetine controlled release compositions

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALLGULANDER CHRISTER ET AL: "Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder.", PSYCHOPHARMACOLOGY BULLETIN, vol. 34, no. 2, 1998, pages 165 - 166, XP008013522, ISSN: 0048-5764 *
CASACALENDA N ET AL: "Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.", CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE. CANADA SEP 1998, vol. 43, no. 7, September 1998 (1998-09-01), pages 722 - 730, XP008013523, ISSN: 0706-7437 *
IANCU IULIAN ET AL: "Anxiety disorders in the elderly: Treatment considerations.", INTERNATIONAL ACADEMY FOR BIOMEDICAL AND DRUG RESEARCH, vol. 13, 1998, disorders in the elderly: New Therapeutic approaches. 1998 S. Karger AG; S. Karger AG P.O. Box, Allschwilerstrasse 10, CH-4009 Basel, Switzerland; New York, New York, USA, pages 51 - 61, XP008013521, ISBN: 3-8055-6536-4 *
ISAAC M: "WHERE ARE WE GOING WITH SSRIS?", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, vol. 9, no. SUPPL 3, 1999, pages S101 - S106, XP000881160, ISSN: 0924-977X *
RAVIZZA LUIGI ET AL: "Antidepressant use in generalized anxiety disorder.", INTERNATIONAL ACADEMY FOR BIOMEDICAL AND DRUG RESEARCH, vol. 12, 1997, therapeutic indications of antidepressants. 1997 S. Karger AG; S. Karger AG P.O. Box, Allschwilerstrasse 10, CH-4009 Basel, Switzerland; New York, New York, USA, pages 41 - 48, XP008013519, ISBN: 3-8055-6436-8 *
ROCCA P ET AL: "Paroxetine efficacy in the treatment of generalized anxiety disorder.", ACTA PSYCHIATRICA SCANDINAVICA, vol. 95, no. 5, 1997, pages 444 - 450, XP008013520, ISSN: 0001-690X *
See also references of WO9953919A1 *

Also Published As

Publication number	Publication date
CA2328896A1 (en)	1999-10-28
NO20005286L (no)	2000-12-20
BR9909791A (pt)	2000-12-26
NO20005286D0 (no)	2000-10-20
IL139167A0 (en)	2001-11-25
WO1999053919A1 (en)	1999-10-28
EP1073437A1 (en)	2001-02-07
JP2002512189A (ja)	2002-04-23
CZ20003885A3 (cs)	2001-09-12
CN1298301A (zh)	2001-06-06
HUP0101350A3 (en)	2002-06-28
GB9808479D0 (en)	1998-06-17
EA200001088A1 (ru)	2001-04-23
ID27546A (id)	2001-04-12
BG104939A (bg)	2001-09-28
AU3864899A (en)	1999-11-08
PL343494A1 (en)	2001-08-27
SK15672000A3 (sk)	2001-04-09
HUP0101350A2 (hu)	2002-05-29
KR20010034817A (ko)	2001-04-25
AP2000001959A0 (en)	2000-12-31
TR200003082T2 (tr)	2001-01-22

Legal Events

Date	Code	Title	Description
2000-12-22	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-02-07	17P	Request for examination filed	Effective date: 20001017
2001-02-07	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-02-07	AX	Request for extension of the european patent	Free format text: RO PAYMENT 20001017;SI PAYMENT 20001017
2003-04-16	A4	Supplementary search report drawn up and despatched	Effective date: 20030303
2003-10-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2003-12-17	18D	Application deemed to be withdrawn	Effective date: 20030528
2007-11-30	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1034201 Country of ref document: HK

Publication	Publication Date	Title
EP1200086A4 (en)	2009-05-27	THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
GB9811213D0 (en)	1998-07-22	Methods of treating preform elements
GB9824436D0 (en)	1999-01-06	Methods of treatment
GB9905275D0 (en)	1999-04-28	Treatment of conditions associated with membrane-bound receptors and their function
EP1071339A4 (en)	2003-07-02	TREATMENT OF ANIMALS BY DIHYDROXYCHINOLINE COMPOUNDS
EP1187604A4 (en)	2004-02-11	CONNECTIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS FAILURES
ID27214A (id)	2001-03-08	Triazolopiridina untuk pengobatan gangguan trombosis
IL140540A0 (en)	2002-02-10	Treatment of anxiety disorders
HUP0101350A3 (en)	2002-06-28	Treatment of generalized anxiety disorder with paroxetine
IL149533A0 (en)	2002-11-10	Treatment of sle with dehydropiandrosterone
IL126681A0 (en)	1999-08-17	Treatment of trauma-related conditions
HK1034201A (en)	2001-10-19	Treatment of generalized anxiety disorder with paroxetine
PL345261A1 (en)	2001-12-03	Method of treatment
HUP9904062A3 (en)	2001-03-28	Fixing rail with holes and process for making of fixing rail
GB2365419B (en)	2002-09-11	Treatment of effluents
GB9819800D0 (en)	1998-11-04	Treatment of fibres
GB9917590D0 (en)	1999-09-29	Treatment of fibres
GB9818295D0 (en)	1998-10-14	Treatment of alopecia
GB9822681D0 (en)	1998-12-09	Method of treatment
SI1117403T1 (en)	2004-04-30	Mglur5 antagonists for the treatment of pain and anxiety
GB9800707D0 (en)	1998-03-11	Methods of treatment
GB9824208D0 (en)	1998-12-30	Methods of treatment
GB9926359D0 (en)	2000-01-12	Treatment of alopecia
DK82798A (da)	1998-05-28	Treatment of GABA-uptake related disorders
HK1045651A (en)	2002-12-06	Methods for treating or preventing pain and anxiety